In endometrial cancer, enhanced activity of the TGF-β/Smad pathway is correlated with tumor progression, metastasis, and recurrence (112), and its implication in the malignant phenotype of endometrial tumors also promotes cell stemness (113, 114). The gene discussed is TGFB1; the disease is endometrial cancer.